SIGA Technologies (id:6573 SIGA)
6.28 USD
Opening hours: 09:30 - 16:00 (Eastern Standard Time: 11/21/2024 7:09:43 PM)
Exchange closed, opens in 14 hours 20 minutes
About SIGA Technologies
Market Capitalization 441.28M
SIGA Technologies, Inc., a commercial-stage pharmaceutical company, focuses on the health security related markets in the United States. Its lead product is TPOXX, an oral formulation antiviral drug for the treatment of human smallpox disease caused by variola virus. The company was incorporated in 1995 and is headquartered in New York, New York.
| Headquarters (address) |
31 East 62nd Street New York 10065 NY United States |
| Phone | 212 672 9100 |
| Website | https://www.siga.com |
| Employees | 45 |
| Sector | Healthcare |
| Industry | Drug Manufacturers Specialty & Generic |
| Ticker | SIGA |
| Exchange | NASDAQ Stock Exchange |
| Currency | USD |
| 52 week range | 4.26 - 12.83 |
| Market Capitalization | 441.28M |
| Dividend yield forward | 38.40 % |
| Dividend yield forward United States (ID:6, base:1863) | 4.21 % |
| P/E trailing | 5.15 |
| P/E forward | 4.98 |
| Price/Sale | 2.54 |
| Price/Book | 2.60 |
| Beta | 0.886 |
| EPS | 1.20 |
| EPS United States (ID:6, base:3395) | 24.30 |
Forward Annual Dividend Yield
Forward Annual Dividend Yield: SIGA Technologies has raised their dividend 38.40 years in a row. This is below the 41124.611400 year average in the 'Drug Manufacturers Specialty & Generic' industry
Forward Annual Dividend Yield
Forward Annual Dividend Yield: SIGA Technologies has raised their dividend 38.40 years in a row. This is below the 41124.611400 year average in the 'Drug Manufacturers Specialty & Generic' industry